MediWound Ltd. is projected to rise to $16.05 by 2027, a +12% move from its current price of $14.29. MDWD is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $14.00 | $14.29 | $14.58 | -0.03% |
| Jul 13 | $13.87 | $14.28 | $14.70 | -0.06% |
| Jul 14 | $13.78 | $14.28 | $14.79 | -0.10% |
| Jul 15 | $13.70 | $14.27 | $14.87 | -0.13% |
| Jul 16 | $13.63 | $14.27 | $14.94 | -0.16% |
| Jul 17 | $13.57 | $14.26 | $15.00 | -0.19% |
| Jul 18 | $13.51 | $14.26 | $15.05 | -0.22% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $13.51 | $14.26 | $15.05 | -0.22% |
| Week 2 | $13.18 | $14.23 | $15.36 | -0.45% |
| Week 3 | $12.92 | $14.19 | $15.59 | -0.67% |
| Week 4 | $12.71 | $14.16 | $15.78 | -0.89% |
| Week 5 | $12.52 | $14.13 | $15.95 | -1.11% |
| Week 6 | $12.35 | $14.10 | $16.10 | -1.34% |
| Week 7 | $12.19 | $14.07 | $16.23 | -1.56% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
MediWound Ltd. is a biopharmaceutical company that develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States, Germany, Italy, Spain, and internationally.
It markets NexoBrid, a biopharmaceutical product for the removal of eschar in patients with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. It also develops EscharEx, a bromelain-based, bioactive enzymatic therapy for the treatment of chronic wounds and other hard-to-heal wounds; and MW005, a topically applied biological product candidate to treat non-melanoma skin cancers.
MediWound was incorporated in 2000 and is headquartered in Yavne, Israel.
MediWound Ltd. (MDWD) is trading at $15.19 with a market cap of $195.23M and a rank of 3831.
The 30-day technical picture shows a NEUTRAL sentiment with RSI14 at 60. The 50-day moving average is $15.65 and the 200-day moving average is $17.26.
The near-term support is $13.73 and resistance is $16.89. The 30-day price range runs from $13.08 to $17.65, indicating a window for near-term movement.
A major floor 9.4% below — a decisive break under it would weaken the trend.
The nearest floor, 3.9% below — buyers have tended to step in here.
The nearest ceiling, 6.3% above — a clean break opens room to run.
A major ceiling 24.9% above — clearing it would confirm fresh momentum.
Key MDWD support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of MDWD market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $14.66 | Sell | $14.61 | Sell |
| MA 10 | $14.82 | Sell | $14.66 | Sell |
| MA 20 | $14.51 | Sell | $14.68 | Sell |
| MA 50 | $15.26 | Sell | $15.17 | Sell |
| MA 100 | $16.16 | Sell | $15.90 | Sell |
| MA 200 | $17.13 | Sell | $16.68 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 43.87 | Neutral |
| Stoch RSI (14) | 33.32 | Neutral |
| CCI (20) | -39.93 | Neutral |
| Williams %R (14) | -73.17 | Info |
| MACD (12,26,9) | 0.05 | Buy |
| ROC (12) | 1.56 | Buy |
| Bollinger %B (20,2) | 0.37 | Neutral |
| Stochastic %K (14) | 26.83 | Neutral |
| TRIX (15) | -0.15 | Sell |
| Awesome (5,34) | 0.07 | Buy |
| Ultimate (7,14,28) | 44.12 | Neutral |
| Momentum (10) | -0.30 | Sell |
| Aroon Osc (25) | 64.00 | Buy |
| Hull MA (9) | 14.56 | Sell |
| ADX (14) | 12.43 | Neutral |
| ATR (14) | 0.30 | Info |
RSI14 is 60, indicating a NEUTRAL momentum, with sentiment marked as NEUTRAL. The 50-day moving average is $15.65 and the 200-day moving average is $17.26.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $13.73 | $14.29 | $17.35 | 0% | Neutral | |
| $13.08 | $16.05 | $20.66 | +12% | Neutral | |
| $13.22 | $16.57 | $21.94 | +16% | Neutral | |
| $12.78 | $16.28 | $22.05 | +14% | Neutral | |
| $14.73 | $19.04 | $26.29 | +33% | Bullish | |
| $16.83 | $22.05 | $30.96 | +54% | Bullish | |
| $18.43 | $24.45 | $34.85 | +71% | Bullish | |
| $19.75 | $26.51 | $38.31 | +86% | Bullish | |
| $19.51 | $26.46 | $38.73 | +85% | Bullish | |
| $20.44 | $28.02 | $41.49 | +96% | Bullish | |
| $29.07 | $41.75 | $64.99 | +192% | Bullish | |
| $50.71 | $78.71 | $131.92 | +451% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $13.73 | $14.29 | $16.87 | +0.00% |
| August 2026 | $11.83 | $13.87 | $16.63 | -2.95% |
| September 2026 | $11.77 | $13.88 | $16.78 | +0.08% |
| October 2026 | $11.97 | $14.18 | $17.27 | +2.14% |
| November 2026 | $11.88 | $14.12 | $17.29 | -0.43% |
| December 2026 | $11.81 | $14.08 | $17.35 | -0.22% |
Click any year to see its month-by-month MDWD forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect MDWD to range from $13.73 to $17.35 through 2026. The $14.29 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The MDWD price prediction for 2027 points to an average of $16.05 (low $13.08, high $20.66) — a potential gain of +12% on today's $14.29. Price action looks broadly range-bound.
In 2028, MDWD is projected to trade between $13.22 and $21.94, averaging $16.57 — a potential gain of +16% from today's $14.29. That is up +3% on the projected 2027 average. A consolidation phase looks the most probable path here.
MediWound Ltd.'s 2029 outlook centres on $16.28, within a $12.78 to $22.05 range. That is -2% versus the projected 2028 average. That marks a +14% change versus current levels. Price action looks broadly range-bound.
By 2030, MDWD could reach as high as $26.29, with a base case around $19.04 and support toward $14.73 — roughly +33% from $14.29. Buyers look set to stay in control over this stretch.
Expect MDWD to range from $16.83 to $30.96 through 2031. The $22.05 average target implies a +54% move from current prices. That is up +16% on the projected 2030 average. Momentum favours further upside here.
The MDWD price prediction for 2032 points to an average of $24.45 (low $18.43, high $34.85) — a potential gain of +71% on today's $14.29. Buyers look set to stay in control over this stretch.
In 2033, MDWD is projected to trade between $19.75 and $38.31, averaging $26.51 — a potential gain of +86% from today's $14.29. That is up +8% on the projected 2032 average. Momentum favours further upside here.
MediWound Ltd.'s 2034 outlook centres on $26.46, within a $19.51 to $38.73 range. That is 0% versus the projected 2033 average. That marks a +85% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, MDWD could reach as high as $41.49, with a base case around $28.02 and support toward $20.44 — roughly +96% from $14.29. Momentum favours further upside here.
Expect MDWD to range from $29.07 to $64.99 through 2040. The $41.75 average target implies a +192% move from current prices. That is up +49% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The MDWD price prediction for 2050 points to an average of $78.71 (low $50.71, high $131.92) — a potential gain of +451% on today's $14.29. Momentum favours further upside here.
Investing $1,000 in MDWD today (≈ 69.979006 MDWD) could be worth
$5,508.22
+$4,508.22 (+451%) by 2050 · US Dollar
Based on the average projected MDWD price of $78.71 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in MDWDwould be worth at today's price.
$1,000 invested in MDWD on Jul 10, 2025 (≈ 47.415837 MDWD) would be worth
$677.57
-$322.43 (-32.2%) today · 0.68× · US Dollar
Based on a MDWD entry price of $21.09 vs. today's $14.29.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $15.16 | $942.61 | -5.7% |
| 1 month ago | $13.86 | $1,031.02 | +3.1% |
| 3 months ago | $17.85 | $800.56 | -19.9% |
| 6 months ago | $17.23 | $829.37 | -17.1% |
| 1 year ago | $21.09 | $677.57 | -32.2% |
| All time (5.0y) ago | $30.03 | $475.86 | -52.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our MDWD forecast.
Our base-case forecast reaches $29.00 around 2040.
Implied market cap at $29.00: $372.72M
From 2030 onward, the forecast shows bullish sentiment with rising averages and sizable ROIs. In 2030, the avg price is $21.23 and the ROI is 39.8%, with a bullish outlook indicated.
In 2040, the avg price is $46.81 and the ROI is 208.1%, continuing the bullish trajectory.
In 2050, the avg price is $93.05 and the ROI is 512.6%, sustaining the bullish long-term view.
These figures are estimates and not guarantees; market conditions can change and impact outcomes.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $21.23 with a min of $16.19 and a max of $29.86, and an estimated ROI of 39.8% with a BULLISH sentiment.
The forecast turns bullish from 2030 onward, with rising averages and ROIs such as 39.8% in 2030, 208.1% by 2040, and 512.6% by 2050, though these are estimates and not guarantees.
Yes. The 2035 max price is $47.99 and the 2040 max price is $74.96, so prices could exceed $50 by 2040 or later.
Market cap is $195.23M and the stock is ranked 3831.
MediWound Ltd. Community Discussion
0Share your MediWound Ltd. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.